The molecular mechanisms of calpains action on skeletal muscle atrophy

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Skeletal muscle atrophy involves muscle protein loss due to increased proteolysis and/or decreased synthesis.
• Cell signaling pathways regulating muscle atrophy are crucial for understanding this complex process.
• Calpains are increasingly implicated in the dysregulation of proteolysis during muscle atrophy.

Purpose of the Study:

• To review the role of calpains in skeletal muscle atrophy.
• To focus on calpain's interaction with the ubiquitin-proteasome pathway (UPP) and Akt phosphorylation in atrophy.
• To highlight potential therapeutic targets for skeletal muscle atrophy.

Main Methods:

• Literature review of studies on calpains, muscle atrophy, UPP, and Akt signaling.
• Analysis of existing research on the molecular mechanisms linking calpains to muscle wasting.
• Synthesis of findings to elucidate calpain's role in atrophy regulation.

Main Results:

• Abnormally activated calpain contributes to muscle atrophy.
• Calpain's effects on muscle atrophy are mediated through downstream pathways, including the UPP.
• Calpain activation impacts Akt phosphorylation, a key regulator of muscle protein synthesis and degradation.

Conclusions:

• Calpains are significant regulators of skeletal muscle protein turnover.
• Calpain's interplay with the UPP and Akt signaling pathways is central to muscle atrophy.
• Targeting calpain activity may offer novel therapeutic strategies for combating muscle wasting diseases.